<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39210315</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>30</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2334</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>29</Day></PubDate></JournalIssue><Title>BMC infectious diseases</Title><ISOAbbreviation>BMC Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Modelling the long-term health impact of COVID-19 using Graphical Chain Models brief heading: long COVID prediction by graphical chain models.</ArticleTitle><Pagination><StartPage>885</StartPage><MedlinePgn>885</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">885</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12879-024-09777-0</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Long-term sequelae of SARS-CoV-2 infection, namely long COVID syndrome, affect about 10% of severe COVID-19 survivors. This condition includes several physical symptoms and objective measures of organ dysfunction resulting from a complex interaction between individual predisposing factors and the acute manifestation of disease. We aimed at describing the complexity of the relationship between long COVID symptoms and their predictors in a population of survivors of hospitalization for severe COVID-19-related pneumonia using a Graphical Chain Model (GCM).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">96 patients with severe COVID-19 hospitalized in a non-intensive ward at the "Santa Maria" University Hospital, Terni, Italy, were followed up at 3-6 months. Data regarding present and previous clinical status, drug treatment, findings recorded during the in-hospital phase, presence of symptoms and signs of organ damage at follow-up were collected. Static and dynamic cardiac and respiratory parameters were evaluated by resting pulmonary function test, echocardiography, high-resolution chest tomography (HRCT) and cardiopulmonary exercise testing (CPET).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Twelve clinically most relevant factors were identified and partitioned into four ordered blocks in the GCM: block 1 - gender, smoking, age and body mass index (BMI); block 2 - admission to the intensive care unit (ICU) and length of follow-up in days; block 3 - peak oxygen consumption (VO<sub>2</sub>), forced expiratory volume at first second (FEV<sub>1</sub>), D-dimer levels, depression score and presence of fatigue; block 4 - HRCT pathological findings. Higher BMI and smoking had a significant impact on the probability of a patient's admission to ICU. VO<sub>2</sub> showed dependency on length of follow-up. FEV<sub>1</sub> was related to the self-assessed indicator of fatigue, and, in turn, fatigue was significantly associated with the depression score. Notably, neither fatigue nor depression depended on variables in block 2, including length of follow-up.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The biological plausibility of the relationships between variables demonstrated by the GCM validates the efficacy of this approach as a valuable statistical tool for elucidating structural features, such as conditional dependencies and associations. This promising method holds potential for exploring the long-term health repercussions of COVID-19 by identifying predictive factors and establishing suitable therapeutic strategies.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gourgoura</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Economics, University of Perugia, Perugia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rivadeneyra</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>University of Padova, Padua, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Camerino, Camerino, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stanghellini</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Economics, University of Perugia, Perugia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caroni</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>National Technical University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bartolucci</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Economics, University of Perugia, Perugia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Curcio</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Unit of Internal Medicine, Santa Maria Terni Hospital, Terni, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bartoli</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Unit of Clinical Psychology, Santa Maria Terni Hospital, Terni, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferranti</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Unit of Radiology, Santa Maria Terni Hospital, Terni, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Folletti</LastName><ForeName>I</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Medicine and Surgery, University of Perugia, Perugia, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Section of Occupational Medicine, Santa Maria Terni Hospital, Terni, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cavallo</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Unit of Internal Medicine, Santa Maria Terni Hospital, Terni, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanesi</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Unit of Internal Medicine, Santa Maria Terni Hospital, Terni, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dominioni</LastName><ForeName>I</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Unit of Internal Medicine, Santa Maria Terni Hospital, Terni, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine and Surgery, University of Perugia, Perugia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santoni</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Unit of Internal Medicine, Santa Maria Terni Hospital, Terni, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine and Surgery, University of Perugia, Perugia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morgana</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Unit of Internal Medicine, Santa Maria Terni Hospital, Terni, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine and Surgery, University of Perugia, Perugia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pasticci</LastName><ForeName>M B</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>Department of Medicine and Surgery, University of Perugia, Perugia, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious Diseases Unit, Santa Maria Terni Hospital, Terni, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pucci</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Unit of Internal Medicine, Santa Maria Terni Hospital, Terni, Italy. giacomo.pucci@unipg.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine and Surgery, University of Perugia, Perugia, Italy. giacomo.pucci@unipg.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vaudo</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Unit of Internal Medicine, Santa Maria Terni Hospital, Terni, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine and Surgery, University of Perugia, Perugia, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>#20414</GrantID><Agency>Fondazione Cassa di Risparmio di Perugia</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Infect Dis</MedlineTA><NlmUniqueID>100968551</NlmUniqueID><ISSNLinking>1471-2334</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>BMC Infect Dis. 2024 Sep 11;24(1):954. doi: 10.1186/s12879-024-09852-6</RefSource><PMID Version="1">39261830</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007558" MajorTopicYN="N" Type="Geographic">Italy</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017741" MajorTopicYN="N">Survivors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Chain Graph Model</Keyword><Keyword MajorTopicYN="N">Fatigue</Keyword><Keyword MajorTopicYN="N">Graphical Chain Model</Keyword><Keyword MajorTopicYN="N">High resolution computed tomography</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Prevention</Keyword></KeywordList><CoiStatement>None. The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>31</Day><Hour>9</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>31</Day><Hour>9</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>29</Day><Hour>23</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39210315</ArticleId><ArticleId IdType="pmc">PMC11360819</ArticleId><ArticleId IdType="doi">10.1186/s12879-024-09777-0</ArticleId><ArticleId IdType="pii">10.1186/s12879-024-09777-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Worldometer. 2023. https://www.worldometers.info/coronavirus/.Accessed 14 December 2023.</Citation></Reference><Reference><Citation>Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat Med. 2022;28:1461&#x2013;7. 10.1038/s41591-022-01840-0. 10.1038/s41591-022-01840-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization, United States. 2023. https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition. Accessed 14 December 2023.</Citation></Reference><Reference><Citation>Office for National Statistics, Kingdom U. 2023. Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/30march2023. Accessed 14 December 2023.</Citation></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11:16144. 10.1038/s41598-021-95565-8. 10.1038/s41598-021-95565-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Hodgson CL, Broadley T. Long COVID-unravelling a complex condition. Lancet Respir Med. 2023;11:667&#x2013;8. 10.1016/S2213-2600(23)00232-1. 10.1016/S2213-2600(23)00232-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(23)00232-1</ArticleId><ArticleId IdType="pubmed">37475126</ArticleId></ArticleIdList></Reference><Reference><Citation>Iaccarino G, Grassi G, Borghi C, Ferri C, Salvetti M, Volpe M, SARS-RAS Investigators. AGE and Multimorbidity Predict Death among COVID-19 patients: results of the SARS-RAS Study of the Italian society of hypertension. Hypertension. 2020;76:366&#x2013;72. 10.1161/HYPERTENSIONAHA.120.15324. 10.1161/HYPERTENSIONAHA.120.15324</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.120.15324</ArticleId><ArticleId IdType="pubmed">32564693</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long covid-mechanisms, risk factors, and management. BMJ. 2021;374:n1648. 10.1136/bmj.n1648. 10.1136/bmj.n1648</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020;94:91&#x2013;5. 10.1016/j.ijid.2020.03.017. 10.1016/j.ijid.2020.03.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.03.017</ArticleId><ArticleId IdType="pmc">PMC7194638</ArticleId><ArticleId IdType="pubmed">32173574</ArticleId></ArticleIdList></Reference><Reference><Citation>Nair P, Nair CV, Kulirankal KG, Corley EM, Edathadathil F, Gutjahr G, et al. Characterization and predictive risk scoring of long COVID in a south Indiancohort after breakthrough COVID infection; a prospective single centre study. BMC Infect Dis. 2023;23:670. 10.1186/s12879-023-08600-6. 10.1186/s12879-023-08600-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-023-08600-6</ArticleId><ArticleId IdType="pmc">PMC10563355</ArticleId><ArticleId IdType="pubmed">37814234</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. Attributes and predictors of long COVID. Nat Med. 2021;27:626&#x2013;31. 10.1038/s41591-021-01292-y. 10.1038/s41591-021-01292-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauritzen SL, Richardson TS. Chain graph models and their causal interpretations. J Roy Stat Soc. 2002;64:321&#x2013;48. 10.1111/1467-9868.00340.10.1111/1467-9868.00340</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1467-9868.00340</ArticleId></ArticleIdList></Reference><Reference><Citation>Parotto M, Gy&#xf6;ngy&#xf6;si M, Howe K, Myatra SN, Ranzani O, Shankar-Hari M, Herridge MS. Post-acute sequelae of COVID-19: understanding and addressing the burden of multisystem manifestations. Lancet Respir Med. 2023;11:739&#x2013;54. 10.1016/S2213-2600(23)00239-4. 10.1016/S2213-2600(23)00239-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(23)00239-4</ArticleId><ArticleId IdType="pubmed">37475125</ArticleId></ArticleIdList></Reference><Reference><Citation>Curcio R, Poli G, Fabi C, Sugoni C, Pasticci MB, Ferranti R, et al. Exosomal miR-17-5p, miR-146a-3p, and mir-223-3p correlate with Radiologic Sequelae in survivors of COVID-19-Related Acute Respiratory Distress Syndrome. Int J Mol Sci. 2023;24:13037. 10.3390/ijms241713037. 10.3390/ijms241713037</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms241713037</ArticleId><ArticleId IdType="pmc">PMC10488112</ArticleId><ArticleId IdType="pubmed">37685844</ArticleId></ArticleIdList></Reference><Reference><Citation>Kevadiya BD, Machhi J, Herskovitz J, Oleynikov MD, Blomberg WR, Bajwa N, et al. Diagnostics for SARS-CoV-2 infections. Nat Mater. 2021;20:593&#x2013;605. 10.1038/s41563-020-00906-z. 10.1038/s41563-020-00906-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41563-020-00906-z</ArticleId><ArticleId IdType="pmc">PMC8264308</ArticleId><ArticleId IdType="pubmed">33589798</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, ESC Scientific Document Group, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021&#x2013;104. 10.1093/eurheartj/ehy339. 10.1093/eurheartj/ehy339</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehy339</ArticleId><ArticleId IdType="pubmed">30165516</ArticleId></ArticleIdList></Reference><Reference><Citation>Lovibond PF, Lovibond SH. The structure of negative emotional states: comparison of the depression anxiety stress scales (DASS) with the Beck depression and anxiety inventories. Behav Res Ther. 1995;33:335&#x2013;43. 10.1016/0005-7967(94)00075-u. 10.1016/0005-7967(94)00075-u</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0005-7967(94)00075-u</ArticleId><ArticleId IdType="pubmed">7726811</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck JG, Grant DM, Read JP, Clapp JD, Coffey SF, Miller LM, et al. The impact of event scale-revised: psychometric properties in a sample of motor vehicle accident survivors. J Anxiety Disord. 2008;22:187&#x2013;98. 10.1016/j.janxdis.2007.02.007. 10.1016/j.janxdis.2007.02.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.janxdis.2007.02.007</ArticleId><ArticleId IdType="pmc">PMC2259224</ArticleId><ArticleId IdType="pubmed">17369016</ArticleId></ArticleIdList></Reference><Reference><Citation>Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, et al. ERS global lung function Initiative. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40:1324&#x2013;43. 10.1183/09031936.00080312. 10.1183/09031936.00080312</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00080312</ArticleId><ArticleId IdType="pmc">PMC3786581</ArticleId><ArticleId IdType="pubmed">22743675</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28:1&#x2013;e3914. 10.1016/j.echo.2014.10.003. 10.1016/j.echo.2014.10.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.echo.2014.10.003</ArticleId><ArticleId IdType="pubmed">25559473</ArticleId></ArticleIdList></Reference><Reference><Citation>de Simone G, Devereux RB, Daniels SR, Koren MJ, Meyer RA, Laragh JH. Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol. 1995;25:1056&#x2013;62. 10.1016/0735-1097(94)00540-7. 10.1016/0735-1097(94)00540-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0735-1097(94)00540-7</ArticleId><ArticleId IdType="pubmed">7897116</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong KT, Antonio GE, Hui DS, Ho C, Chan PN, Ng WH, et al. Severe acute respiratory syndrome: thin-section computed tomography features, temporal changes, and clinicoradiologic correlation during the convalescent period. J Comput Assist Tomogr. 2004;28:790&#x2013;5. 10.1097/00004728-200411000-00010. 10.1097/00004728-200411000-00010</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00004728-200411000-00010</ArticleId><ArticleId IdType="pubmed">15538152</ArticleId></ArticleIdList></Reference><Reference><Citation>Piepoli MF, Corr&#xe0; U, Agostoni PG, Belardinelli R, Cohen-Solal A, Hambrecht R, Task Force of the Italian Working Group on Cardiac Rehabilitation Prevention; Working Group on Cardiac Rehabilitation and Exercise Physiology of the European Society of Cardiology, et al. Statement on cardiopulmonary exercise testing in chronic heart failure due to left ventricular dysfunction: recommendations for performance and interpretation. Part I: definition of cardiopulmonary exercise testing parameters for appropriate use in chronic heart failure. Eur J Cardiovasc Prev Rehabil. 2006;13:150&#x2013;64. 10.1097/01.hjr.0000209812.05573.04. 10.1097/01.hjr.0000209812.05573.04</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.hjr.0000209812.05573.04</ArticleId><ArticleId IdType="pubmed">16575267</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen JE, Sue DY, Wasserman K. Predicted values for clinical exercise testing. Am Rev Respir Dis. 1984;129:S49&#x2013;55. 10.1164/arrd.1984.129.2P2.S49. 10.1164/arrd.1984.129.2P2.S49</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/arrd.1984.129.2P2.S49</ArticleId><ArticleId IdType="pubmed">6421218</ArticleId></ArticleIdList></Reference><Reference><Citation>Wermuth N. Analyzing social science data with graphical Markov models. In: Green P, Hjort P, Richardson N R, editors. Highly structured stochastic systems. Oxford University Press; 2003. pp. 47&#x2013;52.</Citation></Reference><Reference><Citation>Torgo L. Data Mining with R, learning with case studies. (2nd edition). CRC Press. 2017.</Citation></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ, Long COVID. Major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21:133&#x2013;46. 10.1038/s41579-022-00846-2. 10.1038/s41579-022-00846-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaweethai T, Jolley SE, Karlson EW, Levitan EB, Levy B, McComsey GA, et al. RECOVER Consortium. Development of a definition of Postacute Sequelae of SARS-CoV-2 infection. JAMA. 2023;329:1934&#x2013;46. 10.1001/jama.2023.8823. 10.1001/jama.2023.8823</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2023.8823</ArticleId><ArticleId IdType="pmc">PMC10214179</ArticleId><ArticleId IdType="pubmed">37278994</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizrahi B, Sudry T, Flaks-Manov N, Yehezkelli Y, Kalkstein N, Akiva P, et al. Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study. BMJ. 2023;380:e072529. 10.1136/bmj-2022-072529. 10.1136/bmj-2022-072529</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-072529</ArticleId><ArticleId IdType="pmc">PMC9832503</ArticleId><ArticleId IdType="pubmed">36631153</ArticleId></ArticleIdList></Reference><Reference><Citation>Monteiro AC, Suri R, Emeral IO, Stretch RJ, Cortes-Lopez RY, Sherman A, et al. Obesity and smoking as risk factors for invasive mechanical ventilation in COVID-19: a retrospective, observational cohort study. PLoS ONE. 2020;15(12):e0238552. 10.1371/journal.pone.0238552. 10.1371/journal.pone.0238552</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0238552</ArticleId><ArticleId IdType="pmc">PMC7755188</ArticleId><ArticleId IdType="pubmed">33351817</ArticleId></ArticleIdList></Reference><Reference><Citation>Tadayon Najafabadi B, Rayner DG, Shokraee K, Shokraie K, Panahi P, Rastgou P, et al. Obesity as an independent risk factor for COVID-19 severity and mortality. Cochrane Database Syst Rev. 2023;5:CD015201. 10.1002/14651858.CD015201. 10.1002/14651858.CD015201</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD015201</ArticleId><ArticleId IdType="pmc">PMC10207996</ArticleId><ArticleId IdType="pubmed">37222292</ArticleId></ArticleIdList></Reference><Reference><Citation>Maurya R, Sebastian P, Namdeo M, Devender M, Gertler A. COVID-19 severity in obesity: leptin and inflammatory cytokine interplay in the Link between High Morbidity and Mortality. Front Immunol. 2021;12:649359. 10.3389/fimmu.2021.649359. 10.3389/fimmu.2021.649359</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.649359</ArticleId><ArticleId IdType="pmc">PMC8250137</ArticleId><ArticleId IdType="pubmed">34220807</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedersen SF, Ho YC. SARS-CoV-2: a storm is raging. J Clin Invest. 2020;130:2202&#x2013;5. 10.1172/JCI137647. 10.1172/JCI137647</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI137647</ArticleId><ArticleId IdType="pmc">PMC7190904</ArticleId><ArticleId IdType="pubmed">32217834</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacavalerie MR, Pierre-Francois S, Agossou M, Inamo J, Cabie A, Barnay JL, et al. Obese patients with long COVID-19 display abnormal hyperventilatory response and impaired gas exchange at peak exercise. Future Cardiol. 2022;18:577&#x2013;84. 10.2217/fca-2022-0017. 10.2217/fca-2022-0017</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fca-2022-0017</ArticleId><ArticleId IdType="pmc">PMC9169685</ArticleId><ArticleId IdType="pubmed">35658540</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang L, Wang L, Zhou F, Li J, Liu Y, Yang S. Long-term effects of obesity on COVID-19 patients discharged from hospital. Immun Inflamm Dis. 2021;9:1678&#x2013;85. 10.1002/iid3.522. 10.1002/iid3.522</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iid3.522</ArticleId><ArticleId IdType="pmc">PMC8589408</ArticleId><ArticleId IdType="pubmed">34499804</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Jassas HK, Al-Hakeim HK, Maes M. Intersections between pneumonia, lowered oxygen saturation percentage and immune activation mediate depression, anxiety, and chronic fatigue syndrome-like symptoms due to COVID-19: a nomothetic network approach. J Affect Disord. 2022;297:233&#x2013;45. 10.1016/j.jad.2021.10.039. 10.1016/j.jad.2021.10.039</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2021.10.039</ArticleId><ArticleId IdType="pmc">PMC8541833</ArticleId><ArticleId IdType="pubmed">34699853</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Hakeim HK, Al-Rubaye HT, Almulla AF, Al-Hadrawi DS, Maes M. Chronic fatigue, depression and anxiety symptoms in Long COVID are strongly predicted by Neuroimmune and Neuro-oxidative pathways which are caused by the inflammation during Acute infection. J ClinMed. 2023;12:511. 10.3390/jcm12020511.10.3390/jcm12020511</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12020511</ArticleId><ArticleId IdType="pmc">PMC9865328</ArticleId><ArticleId IdType="pubmed">36675440</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-de-Las-Pe&#xf1;as C, Notarte KI, Macasaet R, Velasco JV, Catahay JA, Ver AT, et al. Persistence of post-COVID symptoms in the general population two years after SARS-CoV-2 infection: a systematic review and meta-analysis. J Infect. 2024;88:77&#x2013;88. 10.1016/j.jinf.2023.12.004. 10.1016/j.jinf.2023.12.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2023.12.004</ArticleId><ArticleId IdType="pubmed">38101521</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza MG, Palladini M, Villa G, De Lorenzo R, Rovere Querini P, Benedetti F. Prevalence, trajectory over time, and risk factor of post-COVID-19 fatigue. J Psychiatr Res. 2022;155:112&#x2013;9. 10.1016/j.jpsychires.2022.08.008. 10.1016/j.jpsychires.2022.08.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2022.08.008</ArticleId><ArticleId IdType="pmc">PMC9391361</ArticleId><ArticleId IdType="pubmed">36029623</ArticleId></ArticleIdList></Reference><Reference><Citation>Sturgill JL, Mayer KP, Kalema AG, Dave K, Mora S, Kalantar A, et al. Post-intensive care syndrome and pulmonary fibrosis in patients surviving ARDS-pneumonia of COVID-19 and non-COVID-19 etiologies. Sci Rep. 2023;13:6554. 10.1038/s41598-023-32699-x. 10.1038/s41598-023-32699-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-32699-x</ArticleId><ArticleId IdType="pmc">PMC10119831</ArticleId><ArticleId IdType="pubmed">37085548</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X, Dong D, Ma D. Thin-section computed Tomography manifestations during Convalescence and Long-Term Follow-Up of patients with severe Acute Respiratory Syndrome (SARS). Med Sci Monit. 2016;22:2793&#x2013;9. 10.12659/msm.896985. 10.12659/msm.896985</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/msm.896985</ArticleId><ArticleId IdType="pmc">PMC4982531</ArticleId><ArticleId IdType="pubmed">27501327</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>